𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adoptive immunotherapy of malignant diseases with allogeneic LAK cells

✍ Scribed by Y. Kimoto; Y. Tanji; T. Tanaka; A. Fujiwara; T. Taguchi

Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
90 KB
Volume
10
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adoptive immunotherapy with allogeneic E
Adoptive immunotherapy with allogeneic Epstein–Barr virus (EBV)-specific cytotoxic T-lymphocytes for recurrent, EBV-positive Hodgkin disease
✍ Kenneth G. Lucas; Donna Salzman; Alejandro Garcia; Qi Sun πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 334 KB πŸ‘ 1 views

## Abstract ## BACKGROUND It has been shown that adoptive immunotherapy with Epstein–Barr virus (EBV)‐specific cytotoxic T‐lymphocytes (CTL) is effective for the treatment of EBV‐induced lymphoproliferative disease in stem cell transplantation recipients and organ transplantation recipients. The r

A phase II study of adoptive immunothera
A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma
✍ Daniel H. Palmer; Rachel S. Midgley; Noweeda Mirza; Elizabeth E. Torr; Forhad Ah πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 286 KB

This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunot